Advantage Partners has made its first acquisition in Vietnam, buying women’s fashion brand Elise Fashion for an undisclosed amount.
GIC Private has led a RMB850 million ($125.5 million) Series C round for Burning Rock, a Chinese cancer diagnostics start-up that is already working with hospitals on products based on DNA sequencing analysis.
Beacon Venture Capital, the VC unit of Thailand’s Kasikornbank, has led a $6.5 million investment in Jitta, a local financial technology provider and stock analysis platform operator.
Chinese ride-hailing app operator Didi Chuxing has invested $100 million in India-based online hospitality platform Oyo to close its $1 billion Series E round announced last year.
Sciwind Biosciences, a Chinese drug developer focused on treating metabolic disorders, has raised RMB200 million ($29 million) in Series A funding led by Legend Capital, with participation from existing investors Shiyu Capital and Beijing-based biotech...
New Zealand’s Direct Capital has acquired a minority stake in local retirement village operator Qestral Corporation for an undisclosed sum.
Singapore’s Temasek Holdings has invested INR 2.7 billion ($38.1 million) in India's Dr. Agarwal’s Healthcare to support the expansion of its publicly listed eyecare chain Dr. Agarwal’s Eye Hospital.
Australia’s Equity Venture Partners (EVP) has closed its second VC fund at A$35 million ($25 million). It will make early-stage investments in local B2B software companies.
UK government-backed development finance institution (DFI) CDC Group has made its first direct investment in Nepal via a $15 million commitment to NMB Bank.
Intudo Ventures has closed its second fund focused exclusively on Indonesian early-stage companies at $50 million. The firm raised $20 million for its debut vehicle last year.
EQT has agreed to acquire a minority stake in VBill, a third-party payment services provider in China that focuses on small and medium-sized enterprises (SME) for RMB378 million ($55.8 million).
TuSimple, a China and US-based developer of autonomous driving technology for trucks, has closed its Series D round at $95 million, achieving a pre-money valuation of $1 billion.
StepStone Group, a provider of private markets advisory and asset management services to institutional investors, has promoted Beijing-based Vincent Hsu to partner.
Cube Highways and Infrastructure, the India toll road and transportation investment platform of I Squared Capital, has agreed to acquire two toll road assets owned by Indian infrastructure developer KNR Constructions for INR1.9 billion ($26.7 million).
Indonesia’s BeliMobilGue, a used car trading platform backed by a number of VCs, has raised $10 million in a Series A round led by parent company Frontier Car Group with participation from Toyota Tunas Indonesia.
Australia’s Future Fund expanded its PE exposure by more than one third over the course of 2018, with the sovereign wealth fund citing carefully cultivated private markets exposure as one of the reasons it has comfortably outperformed superannuation...
Warburg Pincus has backed a $200 million funding round for Indonesian shopping mall developer NWP Retail.
Sequoia Capital India has led a $226 million Series D round for Singapore-based Zilingo, a fashion e-commerce platform and provider of ancillary services.
Allianz Investment Management, a unit of insurance giant Allianz Group, has invested over $200 million in a private debt platform managed by Edelweiss Alternative Asset Advisors, the alternative investment arm of India’s Edelweiss Group.
Vision Knight Capital has led a RMB200 million ($29 million) Series C round for Soocas, a Shenzhen-based manufacturer of personal care products such as electric toothbrushes and hairdryers.
C-Bridge Capital has announced a licensing agreement with Samsung Bioepis that is intended to help the Korean biopharmaceutical specialist expand into the China market.
KKR has made the second investment from its global impact fund in Asia, participating in the previously-announced acquisition of Indian environmental services provider Ramky Enviro Engineers (REEL).
Shanghai-based cancer drug developer HaiHe Biopharma has raised $146.6 million in a funding round led by Chinese private equity firm Huagai Capital.
TPG Capital has closed its seventh pan-Asian fund at $4.6 billion after approximately two years in the market. The vehicle is already 40% committed across 12 companies.